(Sharecast News) - Tooru said on Monday that it expected its operating subsidiaries to deliver a strong EBITDA performance for 2025, with trading momentum continuing into the first quarter of 2026.
The AIM-traded health and wellness group said its operating businesses generated average monthly gross revenue of around £1m in the first quarter, alongside EBITDA of £150,000.
It said those levels were expected to increase as OAF builds its market presence and Pulsin benefits from fresh capital investment and wider distribution.
Tooru said Juvela was performing in line with expectations, while OAF continued to grow strongly.
The brand has launched with Asda, where initial sales are tracking ahead of expectations, and is introducing new product lines into Tesco, including Softie Sub Rolls.
The company said OAF's attendance at the Allergy and Free From Show in Birmingham had generated strong engagement with consumers and retail partners, helping to build brand awareness.
Pulsin had returned to growth after a period of consolidation and range optimisation, Tooru said.
The brand maintained strong representation across key retail channels, with good shelf availability, and was benefiting from new investment and a contract manufacturing arrangement that had supported improved margins.
Tooru also said it was continuing to explore debt funding structures for the potential acquisition of Mylky, following the signing of terms.
The proposed deal includes the issue of Tooru shares at 0.77p each, compared with the current share price of 0.19p.
The board said the acquisition could add significant scale and earnings capability to the group, and remained keen to complete the transaction.
Chief executive Scott Livingston said the group was seeing "encouraging momentum" across its portfolio, with strong EBITDA delivery, growing revenue and progress at Juvela, OAF and Pulsin.
"OAF's expansion into major retailers and Pulsin's return to growth demonstrate the strength of our brands and the opportunities ahead," he said.
"Going forward, we firmly believe that the Group is well positioned to accelerate growth and continue building value across the portfolio."
At 1058 BST, shares in Tooru were down 1.35% at 0.18p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
Market News

* Hopes fade for Strait of βHormuz breakthrough


* Hopes fade for Strait of Hormuz βbreakthrough


* Hopes fade for Strait of Hormuz breakthrough


Tooru PLC - AIM-listed company focused on the branded health and wellness sector - Decides not to progress the proposed acquisition of Mylky BV. Expla...


(Sharecast News) - Tooru said on Friday that it had decided not to proceed with its proposed acquisition of Mylky, citing market conditions, geopoliti...


(Alliance News) - Tooru PLC on Monday said positive momentum seen at the end of 2025 has continued into the current year.


(Sharecast News) - Tooru said on Monday that it expected its operating subsidiaries to deliver a strong EBITDA performance for 2025, with trading mome...


Tooru PLC - London-based plant-based and free-from food company - Says it is "highly encouraged" by a strong start to 2026. It says Pulsin returns to ...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.


The themes identified by Greggs align closely with the areas in which Tooru Plc, the AIM listed health and wellness group, is focused.


Scott Livingston, Chief Executive of Tooru Plc, has set out how the groupβs recent Β£980,000 will underpin growing commercial traction and position the...